Ii-Key-SARS-CoV-2 vaccine generates vaccine-specific antibodies and T cell responses in a transgenic mouse model The Ii-Key vaccine elicits both CD4+ T Helper cell (Th1) and CD8+ responses that are ...

MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company ...

Generex’s Ii-Key peptide vaccines for infectious disease and cancer have been studied in human clinical trials involving over 300 subjects in Phase I and Phase II ...

MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has relaunched its corporate website to provide details on a revamped ...

Generex made an initial payment of $400,000 on November 27, 2018 to secure the agreement, and the company is in the process of completing the legal documents with a plan to close the transaction in ...

Filing of up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Recording and transcript of shareholders conference call available at www.generex.com “Lastly, it is important to note ...

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS) ...

Generex to receive $10M in common stock, a warrant, & $1M in R&D funding WORCESTER, Mass. and TORONTO, April 23, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) ...

Generex, a biotech company based in Miramar, issued a shareholder alert Wednesday warning that allegedly illicit activity has adversely affected its share price. The company said it believes ...

Company Receives Independent Appraisal of Breast Cancer Vaccine in Excess of $300 Million at Its Current Stage of Development WORCESTER, Mass., Jan. 25, 2011 /PRNewswire/ -- Generex Biotechnology ...

Announces Commercial Launch of FDA Approved Excellagen®, Proprietary, Patented Wound Care Product Focused on the Treatment of Complicated Wounds including Diabetic Ulcers and 16 Other FDA Approved ...